LGALS3 and cancer: Another recently described MoA by which Gal-3 regulates the local immune response is via its interaction with chitinase-3-like-1 protein, a glycoprotein secreted by a variety of cancer cells, increasing its ability to reprogram monocyte-derived macrophages into a protumor-M2-like immunosuppressive phenotype [78].